pCR | OR | 95% CI | p |
---|---|---|---|
Age | |||
< 50 | |||
≥ 50 | 0.45 | 0.3–0.7 | 0.001 |
Clinical stage | |||
I-II | |||
III | 0.34 | 0.2–0.6 | 0.0001 |
Histological grade (SBR) | |||
II | |||
III | 1.19 | 0.7–1.9 | 0.5 |
Tumor subtypes | |||
HER2+ | 1.6 | 0.7–3.8 | 0.2 |
HR+/Her2- | |||
TNBC | 1.0 | 0.5–2.3 | 0.9 |
VD level | |||
< 20 ng/mL | |||
≥ 20 ng/mL | 0.43 | 0.2–0.8 | 0.01 |